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Abstract Mesenchymal stem cell differentiation of
osteoblasts is triggered by a series of signaling processes
including integrin and bone morphogenetic protein (BMP),
which therefore act in a cooperative manner. The aim of
this study was to analyze whether these processes can be
remodeled in an artificial poly-(L)-lactide acid (PLLA)
based nanofiber scaffold. Matrices composed of PLLA-
collagen type I or BMP-2 incorporated PLLA-collagen
type I were seeded with human mesenchymal stem cells
(hMSC) and cultivated over a period of 22 days, either
under growth or osteoinductive conditions. During the
course of culture, gene expression of alkaline phosphatase
(ALP), osteocalcin (OC) and collagen I (COL-I) as well as
Smad5 and focal adhesion kinase (FAK), two signal
transduction molecules involved in BMP-2 or integrin
signaling were analyzed. Furthermore, calcium and colla-
gen I deposition, as well as cell densities and proliferation,
were determined using fluorescence microscopy. The
incorporation of BMP-2 into PLLA-collagen type I
nanofibers resulted in a decrease in diameter as well as pore
sizes of the scaffold. Mesenchymal stem cells showed
better adherence and a reduced proliferation on BMP-
containing scaffolds. This was accompanied by an increase
in gene expression of ALP, OC and COL-I. Furthermore
the presence of BMP-2 resulted in an upregulation of FAK,
while collagen had an impact on the gene expression of
Smad5. Therefore these different strategies can be com-
bined in order to enhance the osteoblast differentiation of
hMSC on PLLA based nanofiber scaffold. By doing this,
different signal transduction pathways seem to be up
regulated.
1 Introduction
The reconstruction of large bony defects after injury or
tumor resection often requires the use of bone substitution.
In Europe 500,000 surgeries/year require bone graft
material [1]. Therefore artificial scaffolds based on syn-
thetic biomaterials such as metals, polymers, porous
ceramics, hydroxyl apatite, collagen sponge or hydrogels,
and composites have been developed [2–8].
Among them, scaffolds based on nanofibers or nano-
scaffolds offer great advantages [9, 10]. They are thought
to mimic the extracellular matrix (ECM) [11–14] and allow
the differentiation of human mesenchymal stem cells
(hMSC) towards osteoblasts. However, this process
depends on the chemical composition of the nanofibers.
In comparison to other a-(hydroxyester)-based nanofi-
brous scaffolds, poly-(L)-lactide acid (PLLA) scaffolds
supported the highest rate of proliferation of mesenchymal
stem cells [15] with a tendency to higher cell densities
[16, 17]. However, an initial down regulation of genes
associated with the osteoblast linage [16, 18] can be
observed on PLLA nanofibers. This effect can be elimi-
nated by functionalisation of the nanofibers either by
blending with collagen type I [19] or the incorporation by
recombinant bone morphogenic protein 2 (BMP-2) [16].
Both strategies enhanced the differentiation of mesenchy-
mal stem cells towards osteoblasts. In terms of collagen it
is known that the adhesion to collagen I (COL-I) via the
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a2b1 integrin is sufficient to induce osteogenic differenti-
ation of hMSC’s, even in the absence of exogenous stimuli
[20, 21]. BMP-2 induces different factors involved in the
differentiation of hMSC towards osteoblasts [22–31] and is
necessary to induce bone formation [32–34]. Furthermore
BMP-2 induces the formation of avb-Integrin on osteo-
blasts [35, 36]. These, in interaction with the ECM, influ-
ences the BMP-function [36] resulting in migration,
activation of focal adherence kinase and formation of focal
adhesion [37, 38]. Suzawa et al. [39] found evidence, that
the downstream pathway of integrin is involved in Smad1
signals activated by BMP-2 and provide a possible mech-
anism for cooperation between intracellular signals acti-
vated by integrin and BMP receptors in osteoblastic cells.
In order to analyze whether this cooperative effect can
be utilized in PLLA nanofiber based bone replacement
material we constructed BMP-2 containing PLLA-collagen
type I blended nanofiber scaffolds and analyzed their
ability to induce osteoblast differentiation of hMSC.
2 Materials and methods
2.1 Construction of nanofibers and characterization
The preparation of PLLA and PLLA-collagen type I blend
nanofibers as well as the incorporation of BMP-2 into PLLA
nanofibers by electrospinning has been reported in detail earlier
[16, 19, 40]. Briefly, a 4% (w/w) PLLA (Resomer L210,
Boeringer Ingelheim Germany) solution in dichloromethane
(DCM) was prepared at room temperature by stirring overnight
until a homogenous solution was obtained. Spinning process
was performed at a flow rate of 14 ll/min with an applied
voltage of 20–30 kV and a distance of 15 cm. The spinning
solution had a surface tension of 28.34 ± 0.03 mN/m, a vis-
cosity of 1.561 PaS and a conductivity of*0 ls/cm. Samples
of non woven PLLA nanofibers were fixed on 18 mm cover
slips for cell culture experiments.
To incorporate collagen type I into the nanofibers,
PLLA and collagen were dissolved in hexafluoroisopro-
panol (HFIP) in a 4:1 ratio resulting in a 4.5% (w/v)
polymer solution. Here the spinning solution had a surface
tension of 18.33 ± 0.03 mN/m, a viscosity of 1.529 PaS
and a conductivity of *4.7 ls/cm. Spinning process was
performed at a flow rate of 14 ll/min with an applied
voltage of 10–18 kV and a distance of 15 cm.
In order to incorporate BMP-2 into the nanofibers, 25 lg
lyophilized BMP-2 (Reliatech, Braunschweig Germany) was
dissolved in 125 ll 50 mM acetic acid and stabilized by the
addition of 25 ll fetal calf serum (FCS). This mixture was
emulsified in 2.5 ml of a 4.5% PLLA-collagen type I solution
(4:1) over a period of 1 min using a vortex mixer (MS 2
Minishaker IKA; 2,500 rpm). This solution was sufficient for
the spinning of 50 cover slips with BMP-2 depending on the
spinning and fiber collection process. Spinning process was
performed at a flow rate of 14 ll/min with an applied voltage of
10–18 kV and a distance of 15 cm. In some experiments BMP
was replaced by a fluoresceinisothiocyanat (FITC)-labeled
protein, to analyze the distribution within the nanofibers and
release of growth factors form the PLLA Collagen fibers.
2.2 Pore size distribution
The pore size distribution of the three electrospun scaffold
was determined using a capillary flow porometer (type: CFP-
1200-AEXL, Porous Materials Inc., USA). A wetting liquid,
GalwickTM (Porous Materials Inc., USA) was applied to
spontaneously fill the pores in the scaffold and differential
pressure of nitrogen gas was slowly increased on the sample
to remove the liquid within the pores and permit gas flow.
The differential pressure and flow rates through dry and wet
scaffold were measured. All the required pore structure
characteristics such as pore size at bubble point mean flow
pore and pore size distribution were computed from the
measured differential pressures and gas flow rates [41].
2.3 Scanning electron microscopy
For scanning electron microscopy (SEM), samples were
sputter-coated with gold in an AUTO-306 (BOC Edwards,
Crawley, Sussex, U.K.) high-vacuum coating system and
examined in a SEM (S-4100, Hitachi Ltd., Tokyo, Japan) at
an accelerating voltage of 5 kV in the SE mode.
2.4 Human mesenchymal stem cell isolation,
characterization and culture
HMSC cells were obtained from consenting patients with
the approval of the institutional review board. The indi-
cation for surgery was primary osteoarthritis of the hip.
The patients had no evidence of other bone or auto immune
diseases. The routinely removed bone was obtained from
the proximal femur, while preparing the implant bed.
HMSC were isolated and cultured according to the prepa-
ration of Pittenger et al. [42], with minor modification as
described by Brendel et al. [43].
Within the experiments, hMSCs preparations negative
for CD34 and CD40 and positive for the stem cell markers
CD90 and CD105 were used. In order to ensure the
osteoinductive potential of the obtained cells, gene
expression of alkaline phosphatase (ALP), in response to
dexamethasone, was determined prior to the experiments.
For experiments, hMSC were seeded at a density of
3 9 104 cells/cm2 on cover slips or cover slips coated with
nanofibers in growth medium (DMEM), with low glucose
and glutamine (PAA, Linz, Austria) supplemented with
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10% fetal calf serum (FCS) from selected lots (Biochrom,
Berlin, Germany) and 1% penicillin/streptomycin. Osteo-
genic differentiation was induced according to Jaiswal
et al. [44] after an initial proliferation phase of 3 days.
The medium was replaced every second day of culture.
2.5 Gene expression analysis
RNA was extracted from cell layers at days 2, 4, 10 and 22
(after introduction of osteoinductive conditions) using
Peq Gold total RNA Kit (PeqLab, Erlangen, Germany)
according to the manufacturer and quantified spectromet-
rically. Starting from 1 lg RNA, 20 ll cDNA were syn-
thesized using Verso cDNA Kit (Thermo Fisher Scientific,
Lafayette, USA) with oligo-dT primer in the presence of
dNTP. Quantitative RT–PCR reactions were performed and
monitored using a Mastercycler ep realplex Detection
System (Eppendorf, Hamburg, Germany) and Absolute Blue
QPCR Sybr Green Mix (Thermo Fisher Scientific, Lafay-
ette, USA). Genes of interest were analyzed in cDNA
samples (5 ll for a total volume of 50 ll/reaction) using
DeltaDeltaCt method and CyberGreen. Primers (purchased
at TIB Biomol, Berlin, Germany), cycle temperatures and
incubation times for human alkaline phosphatase (ALP),
collagen I (COL-I), osteocalcin (OC), and 18 s rRNA were
previously described [45–47]. The primer sequence for focal
adhesion kinase (FAK) was 50ACC TCA GCT AGT GAC
GTA TGG -30 and 50CGG AGT CCC AGG ACA CTG TG
30 (gen bank L0518666), PCR Primers for Smad5 were
obtained ready to use form www.realtimeprimers.com.
2.6 Immunofluorescence microscopy
Samples were fixed in acetone/methanol, washed with PBS
(39), and exposed to blocking buffer (1% donkey serum
albumin PBS) over a period of 30 min at room temperature
to minimize non-specific absorption of the antibodies. After
another wash in PBS (39), the cells were incubated with
primary antibodies against COL-I (Abcam, Ab6308, Cam-
bridge, United Kingdom), OC (Acris, BP710, Hiddenhau-
sen, Germany), Ki-67 (Darko, Hamburg, Germany) FAK
(BD Biosciences, San Jose, California, USA) and Smad5
(Santa Cruz Biotechnology, Inc. Heidelberg, Germany).
Visualization was done, after washing in PBS (39) using
cy-2- or cy-3-conjugated secondary antibody (Dianova,
Hamburg, Germany) at room temperature (1 h). The slices
were stained with DAPI and embedded in mounting med-
ium. Fluorescence microscopy was done using a Leica
DM5000. Microphotographs of at least three different areas
were made and intensity of fluorescence was determined
using Quips analysis software. Total cell count of DAPI
stained nuclei were obtained. Patient series were analyzed by
independent observers.
2.7 Detection of calcium deposition
Von Kossa staining was performed using 1% aqueous sil-
ver nitrate solution for 1 h followed by several washing
steps in distilled water and incubation in 5% sodium
thiosulfate for 5 min. Alizarin red staining was performed
using 2 g/100 ml at pH 4.1–4.3.
2.8 Statistics
All values were expressed as mean ± standard error of at
least three different patients and compared using student’s
t-test or ANOVA with Bonferroni as a post hoc test. Values
of P \ 0.05 were considered to be significant. Significant
values were marked with *.
3 Results
3.1 Characterization of PLLA collagen blend
nanofibers with or without BMP-2 incorporation
Scanning electron microscopy of electrospun PLLA nanof-
ibers revealed a 3-D non-woven network with a diameter of
0.775 ± 0.294 lm. Fibers were porous in structure.
The PLLA-collagen type I blend nanofibers revealed a 3-D
non-woven network with a diameter of 0.421 ± 0.023 lm
for the blend (Fig. 1c). The PLLA-collagen type I blend
nanofibers presented themselves with a relatively smooth
surface (Fig. 1a). The pore size of the resulting scaffolds was
about 2 lm as demonstrated in Fig. 1d.
The incorporation of BMP-2 into these fibers reduced the
diameter to 0.217 ± 0.009 lm and resulted in a smaller pore
size (approximately 0.6 lm) as shown in Fig. 1b and c. When
FITC labelled bovine serum albumin (BSA) was used as a
model for the incorporation of proteins by electrospinning,
fluorescence microscopy showed evidence that the dye was
distributed uniformly within the fibers (Fig. 2a). When these
fibers were incubated in phosphate buffer at 37C, the fluo-
rescence remained within the fiber over a period of 14 days
(Fig. 2b). Nevertheless the sharpness of the fibers becomes
indistinct. Correspondingly using UV–visible-spectroscopy,
no time dependent release could be detected (data not shown).
3.2 Adhesion of mesenchymal stem cells on nanofiber
scaffolds
In order to describe the biological effects of blending
PLLA with collagen as well as the incorporation of BMP-2
into PLLA-collagen type I blend nanofibers, we first ana-
lyzed the adhesion of hMSC on the desired scaffolds. Cells
were seeded on the scaffolds and allowed to adhere over a
period of 12 h. As shown in Fig. 3, during this time,
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approximately three times more cells adhered on PLLA-
collagen type I blend nanofibers. Nevertheless, this effect
was not significant at all. The incorporation of BMP-2 into
the PLLA-collagen type I blend scaffolds resulted in a four
to five fold increase (p = 0.044).
3.3 Growth and proliferation of human hMSC cultured
on nanofibers
Focusing on growth of hMSC, we next cultured the cells
over a period of 22 days on PLLA, PLLA-collagen type I,
and PLLA-collagen type I nanofiber scaffolds containing
BMP-2. Under growth conditions significant differences
between cell densities between PLLA and PLLA-collagen
type I (p = 0.000) as well as PLLA-collagen type I con-
taining BMP-2 (p = 0.015) were found after 22 days
(Fig. 4a).
Under osteoinductive conditions after 4 days of culture
significance was reached (PLLA/PLLA-collagen nanofi-
bers P = 0.001; PLLA-collagen nanofibers containing
BMP-2 (p = 0.000)). In case of PLLA-collagen nanofibers
significant higher cell densities were found over the time
Fig. 1 Fiber characterization. SEM analysis of PLLA-collagen blend (a) and BMP-2 enwoved PLLA-collagen blend nanofibers (b) and the
resulting fiber diameters (c) and pore sizes of the PLLA-collagen blend (d) and BMP-2 enwoved PLLA-collagen blend nanofibers (e)
Fig. 2 Release characteristics of BMP-2 enwoved PLLA-collagen blend nanofibers. Fluorescence microscopy analysis of BMP-2 enwoved
PLLA-collagen blend nanofibers after incubation in aquarius solutions over a period of 1 (a) and 14 days (b)
1756 J Mater Sci: Mater Med (2011) 22:1753–1762
123
course of the experiment as compared to PLLA nanofibers
(day 10, P = 0.004; day 22, P = 0.003). At these time
points no significant differences between PLLA and PLLA-
collagen type I nanofibers containing BMP-2 were detected
(Fig. 4b). This growth pattern was reflected in the gene
expression of Cyclin 1D (CCND) normalized to 18 s. Here
the gene expression was increased when cells were cul-
tured on PLLA-collagen type I blend nanofibers as com-
pared to PLLA nanofibers. Furthermore the presence of
BMP-2 resulted in a reduced CCND gene expression
(Fig. 4f). Consequently this pattern could be detected using
Ki67 staining (Fig. 4c, d, e).
Fig. 3 Influence of PLLA, PLLA-collagen blend and BMP-2
containing PLLA-collagen blend nanofibers on adhesion
Fig. 4 Influence of PLLA, PLLA-collagen blend and BMP-2
containing PLLA-collagen nanofibers on growth and proliferation
of hMSC cultured under growth and osteoinductive conditions. Time
course of cell densities cultured under growth (a) and osteoinductive
(b) conditions. Immunofluorescence microphotographs of
proliferation as determined by Ki67 staining of hMSC cultured under
osteoinductive conditions on cover PLLA nanofibers (c), PLLA-
collagen blend nanofibers (d) and BMP-2 enwoved PLLA-collagen
blend nanofibers (e). Gene expression of CCND after 4 days of cell
culture as compared to PLLA (f)
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3.4 Influence of PLLA-nanofibers
on the differentiation and matrix formation
of hMSC
To examine the influence of incorporation of BMP-2 into
PLLA-collagen type I on hMSC differentiation into osteo-
blasts we compared the gene expression of alkaline phos-
phatase, collagen type-I and osteocalcin of cells, grown on
PLLA-collagen type I blend nanofibers with or without
BMP-2. Although there was a broad inter-assay variability
(mainly responsible for the lack of significance) the presence
of BMP-2 resulted in an increase of alkaline phosphatase and
osteocalcin (Fig. 5a, b). The reason why osteocalcin and
alkaline phosphatase expression was increased in the early
stage and decreased during the time course is due to the ddCT
method used to compare expression between the scaffolds at
each time point and not in a time dependent manor. Here von
Kossa as well as alizarin staining gave evidence that
osteogenesis was more dominant when cells were cultured
under osteoinductive conditions. Furthermore when BMP
was incorporated this effect seems to be enhanced (Fig. 5c).
This was accompanied by a significant increase in the
gene expression of collagen type I (Fig. 6a) when cells
were cultured on BMP-2 containing nanofiber scaffolds as
compared to PLLA-collagen nanofibers alone. This effect
was independent from culture conditions and resulted in an
enhanced deposition of the corresponding proteins in the
nanofiber scaffolds over a period of 22 days as demon-
strated by immunofluorescence (Fig. 6b, c, d, e).
3.5 Influence of nanofiber composition signal
transduction
Because collagen blended PLLA nanofibers [19] as well as
BMP-2 containing PLLA nanofibers [16] enhance the dif-
ferentiation of mesenchymal stem cells towards osteoblasts
Fig. 5 Influence of BMP-2 containing PLLA-collagen blend nanof-
ibers on differentiation of hMSC towards osteoblasts cultured under
growth and osteoinductive conditions. Time course of alkaline
phosphatase (a) and osteocalcin (b) gene expression of hMSC
cultured under growth and osteoinductive conditions on BMP-2
containing PLLA-collagen blend nanofibers compared to PLLA-
collagen blend nanofibers without BMP. c Alizarin (red) and von
Kossa staining (Black) of hMSC cultured under growth and osteo-
inductive conditions on different nanofiber scaffolds (Color figure
online)
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and additionally integrin activation by collagen was
involved in BMP signals in osteoblastic MC3T3-E1 cells
[39] we next analyzed the occurrence of FAK and Samd5
(which are key regulator molecules in the corresponding
pathways) using real time PCR and fluorescence micros-
copy. As compared to PLLA nanofibers alone, the PLLA
collagen type I nanofibers showed an increased expression
gene of the FAK gene (Fig. 7) which resulted in an increase
of FAK within the cells. This effect was boosted when BMP-
2 was incorporated into the PLLA collagen type I nanofibers.
Similar findings were made with respect to Smad5 (Fig. 8),
although the elicited effects by BMP-2 were two times
higher as compared to FAK gene expression.
4 Discussion
Tissue-engineering scaffolds should be analogous to native
ECM in terms of both chemical composition and physical
structure. Polymeric nanofiber matrix, with its nanoscaled
nonwoven fibrous structure is a candidate for ECM-
mimetic material [48]. Besides the structural effects (elic-
ited by the nanofibers) signals mediated by growth factors
and/or collagen sequences like RGD-integrin system are
important to develop artificial tissue. In case of bone
regeneration, members of the TGF-ß superfamily, the bone
morphogenetic proteins are necessary [28–31]. We dem-
onstrated earlier that the incorporation of BMP-2 into
PLLA nanofiber scaffolds by electrospinning is useful to
enhance the osteoblastic differentiation of hMSC as
determined by an increased gene expression of genes
associated with the osteoblast [16]. Furthermore it was
shown, that BMP-2 induces the formation of avb-integrins
on osteoblasts [35, 36]. These—in interaction with the
ECM—influence the BMP-2 function [36]. Beyond that,
Fig. 6 Influence of PLLA-collagen blend nanofibers and BMP-2
containing PLLA-collagen blend nanofibers on collagen type-I gene
expression and matrix deposition of hMSC cultured under growth and
osteoinductive conditions. Time course of gene expression of hMSC
cultured under growth and osteoinductive conditions (a). Immuno-
fluorescence microphotographs of COL-I (red) deposition after
22 days of culture on PLLA-collagen blend nanofibers (b) BMP-2
containing PLLA-collagen blend nanofibers under growth conditions
(c) or osteoinductive conditions (d, e)
Fig. 7 Influence of PLLA-collagen blend nanofibers and BMP-2
containing PLLA-collagen blend nanofibers on FAK gene expression
and immunofluorescence detection of FAK in hMSC cultured under
growth and osteoinductive conditions
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the adhesion to collagen via the a2b1 integrin is sufficient
to induce osteogenic differentiation of hMSC’s, even in the
absence of exogenous stimuli [20, 21]. Indeed, this prop-
erty is carried to collagen nanofiber scaffolds [18, 49] as
well as nanofiber scaffolds form other polymers, blended
with collagen [19, 50].
Within this paper we analyzed whether the combination
of both stimuli (BMP-2 and collagen) have a cooperative
effect when incorporated into PLLA nanofibers.
With respect to adhesion, the BMP incorporation into
PLLA-collagen type I nanofibers resulted in an increased
adhesion of hMSC on the nanofibers. Although we cannot
exclude that the differences in pore size or fiber diameter
were involved in this phenomenon, we speculate, that
upregulation of integrins by BMP-2 [35, 36] could be
responsible for this effect. This speculation is supported by
the finding that cells cultured on this fiber type possess
higher gene expression levels as well as protein levels of
focal adhesion kinase, a key regulator of the integrin sig-
naling pathway. However additional studies are necessary
to support this speculation.
As reported earlier, the collagen nanofiber scaffold
increased cell densities [19] as well as proliferation.
The additional incorporation of BMP-2 resulted in a
reduced proliferation and lower cell densities. This can be
explained by the osteoinductive stimulus elicited by BMP-
2. In fact we found an increased gene expression of alka-
line phosphatase and osteocalcin, marker of osteoblast
differentiation. Furthermore this speculation is supported
by an upregulation of Smad5 which is involved in
the BMP-2 signal transduction pathway. In addition, this
effect was enhanced when osteoinductive conditions were
applied. The latter finding is in accordance with coopera-
tive effects between dexamethason and BMP-2 on hMSC
differentiation [51]. Taken together this indicates that
BMP-2 and not the altered fiber size is responsible for the
biological effects on hMSC. Therefore our study indicates
that the nanofiber scaffolds can be used to combine the
activation of different signal transduction pathways.
This facilitates the use of cooperative effects—at least in
the differentiation of hMSC towards osteoblasts.
Whether this is sufficient for a bone replacement
material, depends although on physical prosperities of the
scaffold. The design of scaffolds for bone tissue engi-
neering is based on the physical properties of bone tissue
such as mechanical strength, pore size, porosity, hardness,
overall 3D architecture and—when used as a drug carrier
system—the presentation of the growth factor. Although
PLLA is known to possess poor protein release properties
[52, 53], during electro-spinning process hydrophilic
compounds were accumulated on the fiber surface [54].
The large surface and the porous structure of PLLA
nanofibers, might facilitate contact to the BMP-2 receptor
of the growing cell and elicit differentiation [16]. In case
blend nanofibers similar behavior can be expected. The
latter showed that the growth factor was detectable by
fluorescence microscopy over a period of 14 days.
Although the blend fibers formed a gel-like structure over
time, which was observed earlier in unfixed collagen
blended nanofibers [19], this effect had no impact on the
release kinetics of the incorporated BMP-2. This might be
explained by the collagen binding sequence, presented in
BMP-2 [55, 56], retarding the growth factor without
detectable effect on the BMP-bioavailability. Maybe this
form of BMP-2 presentation is similar to the extra cellular
matrix, facilitating the BMP-2 contact to its receptors.
More problematic might be the pore size of the nano-
fiber scaffolds. For bone tissue engineering, scaffolds with
a pore size in the range of 100–350 lm are preferred for
better cell/tissue in-growth and hence enhanced bone
regeneration [57, 58]. Here the PLLA-collagen type I as
well as the BMP-2 enwoved PLLA-collagen I nanofiber
scaffolds show some disadvantages concerning their pore
size. Whether this might be compensated by the formation
of the gel like structure, or the degradation of collagen after
implantation has to be analyzed in vivo.
Fig. 8 Influence of PLLA-collagen blend nanofibers and BMP-2
containing PLLA-collagen blend nanofibers on Smad5 gene expres-
sion and immunofluorescence detection of smad5 in hMSC cultured
under growth and osteoinductive conditions
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5 Conclusion
It has been shown earlier that PLLA nanofiber scaffolds
can be functionalized by either growth factors or compo-
nents from the ECM. Here we demonstrated that these
different strategies can be combined in order to enhance the
osteoblast differentiation of hMSC. By doing this, different
signal transduction pathways seemed to be up regulated.
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